Search

European AIDS Clinical Society (EACS) interim guidance on the use ...

These recommendations have been developed by representatives from the Comorbidities panel of the EACS Guidelines to inform the use of statin therapy for the ...

https://www.eacsociety.org/media/eacs_interim_guidance_on_statin_use_for_primary_prevention_cvd_in_people_with_hiv_2.pdf

Interim Guidance | EACSociety

This EACS Interim Guidance has been developed to inform the use of statin therapy for the primary prevention of cardiovascular disease in people with HIV in ...

https://www.eacsociety.org/guidelines/interim-guidance/

Versiunea 7.1 Noiembrie 2014

O statină este de preferat în terapia de primă linie; diferite statine au ... 2) medicamente hipolipemiante (statine, fibrate), 3) antihipertensive ...

https://www.eacsociety.org/media/guidelines-7.1-romanian.pdf

EACS Guidelines | EACSociety

EACS produces Guidelines for the management of people living with HIV in Europe. The English version is regularly updated by the guidelines panels.

https://www.eacsociety.org/guidelines/eacs-guidelines/

Versiunea 8.1 Octombrie 2016

Oct 1, 2016 ... intoleranţă la statine sau poate fi adăugat statinelor în situaţia în care reducerea LDL nu este optimă, în ciuda statinei tolerate maxi ...

https://www.eacsociety.org/media/guidelines-8.1-romanian.pdf

RECOMMANDATIONS

Une statine est le traitement de choix en première ligne, les différentes ... (=diminution de l'activité de la statine, ↑ la dose par pallier pour.

https://www.eacsociety.org/media/guidelines-7.1-french.pdf

Version 9.0 Oktober 2017

• Statine sind sicher in der Anwendung, aber haben keinen Einfluss auf die. Lebererkrankung. Dasselbe trifft auf n-3 mehrfach ungesättigte Fettsäuren zu. Bei ...

https://www.eacsociety.org/media/guidelines_9.0-german.pdf

RECOMMANDATIONS Version 9.0 Octobre 2017

(=diminution de l'activité de la statine, ↑ la dose par pallier pour atteindre le bénéfice attendu ii, iii) l'excrétion de la statine associée. vii.

https://www.eacsociety.org/media/guidelines-9.0-french.pdf

RECOMMANDATIONS Version 8.0 Octobre 2015

(=diminution de l'activité de la statine, ↑ la dose par pallier pour atteindre le bénéfice attendu ii, iii) l'excrétion de la statine associée. vii.

https://www.eacsociety.org/media/guidelines-8.0-french.pdf

Version 10.0 November 2019

... Statine(i,ix) atorvastatine(ii). 10-80 mgx 1/j. Troubles gastro- intestinaux, céphalées, insomnies, rhabdomyolyse (rare) et hépatite toxique. Démarrer à faible.

https://www.eacsociety.org/media/french-checked1_1721_.pdf